Risk of rebound hypertension, especially in patients not transitioned from clevidipine to oral antihypertensive therapy after prolonged infusions, should be monitored for at least eight hours ...

There have been several reported cases of rebound hypertension, and the mechanism of this phenomenon is unknown. However, NO release from cultured endothelial cells has been shown to function as a ...